Addition of the p110alpha inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer
Addition of the p110alpha inhibitor BYL719 overcomes targeted therapy resistance in cells from Her2-positive-PTEN-loss breast cancer
复制标题
添加 p110α 抑制剂 BYL719 克服了 Her2 阳性 PTEN 缺失乳腺癌细胞的靶向治疗耐药性
作者：
Chen Zhang;Bingfei Xu;Pian Liu
